Search icon
TCS, HDFCBANK, SBI Liquid Fund (G)
Emcure Pharmaceuticals Ltd.

Symbol

Equity

NSE,BSE

Min. Investment

9,60,000.00

Open a free Demat account and invest in IPOs easily.

Download Orca

Google PlayApp Store

To access realtime data for GP Eco Solutions India Ltd. and use advance features for Applying IPO. Register or Login to Orca.

IPO Details

Bidding Dates

03 Jul 24 - 05 Jul 24

Price Range ₹

960 - 1008

Total Equity

1953.01Cr

Lot Size

14

Exchange Status

NSE,BSE

IPO Doc

Subscription Rate

Non-Institutional Investor

7.21×

Qualified Institutional Buyers

195.83×

Employees

8.81×

Retail Investors

7.21×

Total subscription Rate

67.87×

IPO Timeline

Offer start

03 Jul 2024

Offer end

05 Jul 2024

Allotment

08 Jul 2024

Refund initiation

09 Jul 2024

Demat transfer

09 Jul 2024

Listing

10 Jul 2024

About Company

Emcure Pharmaceutical is a prominent Indian pharmaceutical company that specializes in the development, manufacturing, and global marketing of a wide range of pharmaceutical products. It holds a leading position in India's pharmaceutical market in therapeutic areas such as gynecology, blood-related disorders, and HIV antivirals, based on its impressive sales performance during the Financial Year 2021.Distinguished by its focus on research and development, Emcure is recognized as an innovative company. Its product portfolio encompasses diverse forms of medication, including orals, injectables, and biologics. Additionally, Emcure has ventured into the field of mRNA technology and is actively involved in the development of a COVID-19 vaccine utilizing this platform. This expansion into cutting-edge mRNA technology has allowed Emcure to target a broader range of markets across more than 70 countries worldwide. Emcure's success can be attributed to its commitment to scientific advancement, robust manufacturing capabilities, and global marketing strategies.

Year Founded

16-04-1981

Promotor Details

Berjis Minoo Desai

Promoter Holdings Details

ParticularPre-IPOPost-IPO
Percentage83.2178.11
Share Capital150730468147649282

Offer to Public

1,93,75,070.00 Cr

Project Details

  • General corporate purposes(1) - 0cr
  • General corporate purposes - 1588.64cr
  • Repayment and/or prepayment of all or a portion of certain outstanding borrowings availed by our Com - 6000cr

Objectives

  • Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by our Company
  • andGeneral corporate purposes.

Highlights

  • Emcure excels in creating unique pharmaceutical products for specialized therapeutic areas with limited competition and high entry barriers.
  • Emcure is in a favorable position to capitalize on its dominant market position within India.
  • Emcure possesses an expansive and diverse range of products that are experiencing rapid growth in international markets.
  • Emcure demonstrates robust expertise and a successful history in establishing and developing brands.
  • Emcure has a wide-ranging and varied manufacturing capacity that spans across different products and areas.

Challenges

  • Emcure's ability to maintain or raise its product prices may be impacted by pricing pressure from customers.
  • Emcure faces potential challenges in obtaining, maintaining, or renewing the necessary licenses, permits, and approvals for its business operations.
  • Emcure has not encountered any delays, interruptions, or reductions in the supply or transportation of its raw materials or finished products.
  • Emcure has not experienced any slowdown or shutdown in its manufacturing or R&D operations.
  • Emcure and other entities are subject to an investigation by the Competition Commission of India for alleged cartelization in marketing an oral anti-diabetes formulation, which may result in adverse orders or penalties.

Financials

YearsTotal AssetsShare CapitalProfit After TaxConsolidated Net ProfitAdjusted EPS
202477,093.671,811.521,991.761,977.6116.0177
202166,591.061,808.525,690.665,583.6230.874
202365,734.051,808.521,991.761,977.6116.0177
202058,032.941,808.521,741.891,750.989.6818
202259,473.891,808.521,741.891,750.989.6818
Enrich money logo